RHRana S. Hoda

Rana S. Hoda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rana S. Hoda has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Non‐gynecologic cytology on liquid‐based preparations: A morphologic review of facts and artifacts

    by Rana S. Hoda

    Liquid‐based preparations (LBP) are increasingly being used both for gynecologic (gyn) and non‐gynecologic (non‐gyn) cytology including fine needle aspirations (FNA). The two FDA‐approved LBP currently in use include ThinPrep (TP), (Cytyc Corp, Marlborough, MA) and SurePath (SP), (TriPath Imaging Inc., Burlington, NC). TP was approved for cervico‐vaginal (Pap test) cytology in 1996 and SP in 1999 and both have since also been used for non‐gyn cytology. In the LBP, instead of being smeared, cells are rinsed into a liquid preservative collection medium and processed on automated devices. Even after a decade of use, the morphological interpretation of LBP remains a diagnostic challenge because of somewhat altered morphology and artifacts or facts resulting from the fixation and processing techniques. These changes include cleaner background with altered or reduced background and extracellular elements; architectural changes such as smaller cell clusters and sheets, breakage of papillae; altered cell distribution with more dyscohesion and changes in cellular morphology with enhanced nuclear features, smaller cell size and slightly more three‐dimensional (3‐D) clusters. Herein, we review the published literature on morphological aspects of LBP for non‐gyn cytology. Diagn. Cytopathol. 2007;35:621–634.


  • Routine vaginal Pap test is not useful in women status‐post hysterectomy for benign disease

    by Hanan Farghaly, Danyel Bourgeois, Patricia M. Houser, Vijaylakshmi Padmanabhan, Janice M. Lage, Rana S. Hoda

    The US Preventive Services Task Force (USPTF) has recommended that routine vaginal Pap (V‐Pap) screening is unnecessary for women status‐post (S/P) total hysterectomy (T‐Hyst) for benign disease (Guide to Clinical Preventive Services. 2nd ed. Baltimore, MD: Williams & Wilkins; 1996. p 105–118). However, many US women continue to have V‐Pap despite no risk for cervical cancer and minimal risk for primary vaginal cancer (JAMA 2004;291:2990). Herein, we report our experience with such patients.Computerized data of patients S/P T‐Hyst for benign conditions over a 6‐yr‐period were retrospectively evaluated. Pap diagnoses of epithelial abnormalities (Ep Abnl), negative for intraepithelial lesion or malignancy with/without nonneoplastic findings (NILM‐NN and NILM), were reviewed based on three age groups: group A, 18–44 yr; group B, 45–64 yr; and group C, ≥65 yr (JAMA 2004;291:2990). A control group was used.Of 1,860 T‐Hyst 1,303 (70%) were for benign disease. Of these 581/1303 (44.5%) patients had 819 current V‐Paps (range, 1–5; mean, 1.4). The 581 patients were group A, 288 (49.5%); group B, 272 (46.8%); and group C, 21 (3.6%). Overall, the 819 V‐Paps showed Ep Abnl, 28 (3.4%); NILM‐NN, 252 (30.7%); and NILM, 539 (65.8%). Of the 28 Ep Abnl, 19 (67.8%) were atypical squamous cells of undetermined significance (ASCUS), and 9 (32%) were low‐grade vaginal intraepithelial lesions (LG‐VAIN). The NILM‐NN findings included organisms, atrophy, and endometriosis. On the basis of individual age groups, Ep Abnl were only seen in V‐Paps of 7/288 (2%) of group A and 21/272 (8%) of group B patients. In 23 control patients, 7/71 (9.8%) current V‐Paps showed Ep Abnl (ASCUS, 4 (57%); LG‐VAIN, 3 (43%)).Continued V‐Pap in women S/P T‐Hyst for benign disease does not appear to be useful, particularly in those aged ≥65 yr. Diagn. Cytopathol. 2006;34:640–643. © 2006 Wiley–Liss, Inc.


  • “Wreath cell” in recurrent anaplastic large cell lymphoma

    by J.R. McEvoy, Francois M. Cady, Rana S. Hoda


  • “Fruiting body” ofAspergillus species in a routine cervico-vaginal smear (Pap test)

    by Rana S. Hoda, Cheryl Colello, Martha Roddy, Patricia M. Houser


  • Fine-needle aspiration of a primary mediastinal large B-cell lymphoma: A case report with cytologic, histologic, and flow cytometric considerations

    by Rana S. Hoda, Lee Picklesimer, Kimberly M. Green, Sally Self

    Fine-needle aspiration (FNA) cytology and immunophenotyping by flow cytometry (FCM) are increasingly being used for diagnosing and subclassifying lymphoma in the REAL/WHO classification. Herein, we report a case of primary mediastinal large B-cell lymphoma (PMBL), a subtype of diffuse large B-cell lymphoma in the WHO classification, diagnosed by FNA cytology in conjunction with FCM. This, to our knowledge, has not previously been reported. A 57-yr-old woman presented with bilateral axillary lymphadenopathy and intermittent shortness of breath. CT scan revealed a 5-cm anterior mediastinal mass and mediastinal lymphadenopathy. Endoscopic ultrasound-guided FNA of a 4.5-cm subcarinal lymph node showed medium to large atypical lymphocytes with scant to moderate finely vacuolated cytoplasm. Nuclei were enlarged, cleaved, noncleaved, lobulated, and hyperchromatic. The background showed lymphoglandular bodies. Malignant large cell lymphoma was cytologically diagnosed. FCM, performed on a portion of the FNA specimen, demonstrated large B cells devoid of surface immunoglobulin expression, the characteristic immunophenotype of PMBL. The histologic diagnosis was PMBL. Touch-imprint cytology of the histologic specimen showed large cells with a narrow rim of clear cytoplasm and prominent outer cell border. Nuclear features were similar to the FNA specimen. In the presence of a mediastinal mass, FNA cytology in conjunction with FCM can effectively diagnose PMBL in the appropriate clinical setting. Diagn. Cytopathol. 2005;32:370–373.


  • Open Access

    Disseminated primary diffuse leptomeningeal gliomatosis: a case report with liquid based and conventional smear cytology

    by Masha Bilic, Cynthia T Welsh, Zoran Rumboldt, Rana S Hoda

    Primary diffuse leptomeningeal gliomatosis is a rare neoplasm confined to the meninges without evidence of primary tumor in the brain or spinal cord parenchyma. Cerebrospinal fluid diversion via ventriculoperitoneal shunt may be used as a therapeutic modality. Herein, we describe the first report of cytologic findings of a case of this neoplasm with shunt-related peritoneal metastasis. A 19-year-old male presented with a 6-month history of severe headaches. He had bilateral papilledema on physical exam. Cerebrospinal fluid examination was negative. Four months later a ventriculoperitoneal shunt was placed. Shortly thereafter, he was diagnosed with primary diffuse leptomeningeal gliomatosis based on the biopsy of an intradural extramedullary lesion adjacent to the lumbar spinal cord at a referral cancer center. The histology featured an infiltrating growth pattern of pleomorphic astrocytes with diffuse positivity for glial fibrillary acidic protein. A couple of months later he presented at our institution with ascites and an anterior peritoneal mass. Repeat cerebrospinal fluid cytology and fine needle aspiration of the mass confirmed disseminated gliomatosis. Cytologic characteristics included clusters of anaplastic cells of variable size, high nuclear to cytoplasm ratio and scant to moderate cytoplasm. Occasional single bizarre multinucleated cells were seen with eccentric "partial wreath-like" nuclei, clumped chromatin and prominent nucleoli. Patient expired 13 months after initial presentation. Disseminated primary diffuse leptomeningeal gliomatosis should be considered in the differential diagnosis of chronic aseptic meningitis and in the presence of a peritoneal tumor in patients with ventriculoperitoneal shunts. Immunocytochemistry may be of diagnostic value.


  • Granular Cell Tumor of the Biliary System

    by Rana S. Hoda, Sachiko Minamiguchi, David N. Lewin, William Foody, Grace Weselow, Stephan M. Wildi

    Granular cell tumors (GCTs) of biliary system are rare. GCTs show a striking preponderance for young, black females, who generally present with obstructive jaundice. To our knowledge, these are the first 2 reports of GCT of biliary system identifed on endoscopic brushing cytology. In case 1, a 24-year-old, black woman presented with a 5-month history of pruritus. Radiographic studies demonstrated a mass in the distal common bile duct. Endoscopic biopsy and bile duct brushing were diagnosed as GCT. A Whipple procedure was confirmatory of GCT. In case 2, a 38-year-old, black female presented with a 7-month history of pruritus and jaundice. Radiographic studies showed a stricture of the common hepatic duct at the hilum. Endoscopic brushing cytology of the stricture yielded only a few sheets of granular cells that were missed on initial screening. Suspicion of cholangiocarcinoma prompted surgery, and final histopathology showed GCT. Both patients were well 1 1/2 and 6 years after presentation. GCT of the bile duct can be diagnosed on endoscopic brushing and should be considered in the cytologic differential diagnosis in the appropriate clinical settings.


  • Bile duct brushings on ThinPrep®: Experience with 68 specimens

    by Sachiko Minamiguchi, Rick McEvoy, Mostafa Fraig, David N. Lewin, Michael B. Wallace, Rana S. Hoda